Patents by Inventor Evgeny Ilich Maevsky

Evgeny Ilich Maevsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9248427
    Abstract: A method for production of a bio-safe polymer sorbent for selective binding of Sr and Cs isotopes from a liquid medium for treatment of liquid radioactive wastes is provided. The sorbent with high specific sorption capacity in compliance with the requirements of bio-compatibility and safety with respect to the diverse biological objects, is produced. Also, a raw mixture used for the production of the sorbent has a small weight and a volume in comparison with the given sorbent. The structure of the sorbent is formed by self-assembly during the hydration of the dry mix of the components.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: February 2, 2016
    Inventors: Elena Vladimirovna Orlova, Evgeny Ilich Maevsky, Vladimir Konstantinovich Klubkov, Aleksey Pavlovich Zelisko
  • Publication number: 20150314265
    Abstract: A method for production of a bio-safe polymer sorbent for selective binding of Sr and Cs isotopes from a liquid medium for treatment of liquid radioactive wastes is provided. The sorbent with high specific sorption capacity in compliance with the requirements of bio-compatibility and safety with respect to the diverse biological objects, is produced. Also, a raw mixture used for the production of the sorbent has a small weight and a volume in comparison with the given sorbent.
    Type: Application
    Filed: December 28, 2012
    Publication date: November 5, 2015
    Inventors: Elena Vladimirovna ORLOVA, Evgeny Ilich MAEVSKY, Vladimir Konstantinovich KLUBKOV
  • Publication number: 20150315563
    Abstract: Method for activation of stem cells' proliferation and increase in the resistance of the stem cells to negative impacts, without use of high-frequency electro-magnetic field, is provided. The technical result is achieved due to the treating of the cells culture with a weak low-frequency magnetic field. The proposed method includes: 1) Increase in number of the human stem cells in the culture after their exposure to a weak magnetic field over a representative for the given cell culture doubling half-period (for 24 hours, number of cells increases 2.5 times-at full doubling period of the intact cells equals to 48 hours); 2) Increase of amplitude of self-magnetic irradiation of the initial culture of the stem cells, which indicates increased activity. 3) Double increase in stability of the human stem cells with respect to the development of apoptosis and synchronization of the cells predominantly in G1 phase.
    Type: Application
    Filed: October 2, 2012
    Publication date: November 5, 2015
    Inventors: Elena Vladimirovna ORLOVA, Evgeny Ilich MAEVSKY, Vladimir Konstantinovich KLUBKOV
  • Patent number: 6878826
    Abstract: Tertiary perfluorocycloamines (TPFCAs) of general formula (1) where n=1 or 2, m=2 or 3, X is wherein at n=2 X is as the basis for gas transport emulsions. TPFCAs comprise a group of compounds which are close in their physicochemical properties to perfluoro-N-(4-methylcyclohexyl)-piperidine, particularly in the critical temperature of dissolution in hexane, and which are used in a mixture, forming a number of compounds with gradually varying characteristics. Owing to this, a greater homogeneity of the fluorocarbon phase is achievable in the emulsions and it becomes possible to enhance the stability of the emulsion particles stabilized by an ethylene oxide-propylene oxide block copolymer, with the absence of toxicity for large animals. A mixture of TPFCAs is prepared by electrochemical fluorination of n-piperidinoheptafluorotoluene in anhydrous hydrogen fluoride.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: April 12, 2005
    Assignee: Otkrytoe Aktsionernoe obschestvo Nauchno-proizvodstvennaya firma Perftoran
    Inventors: Lev Lvovich Gervits, Kirill Nikolaevich Makarov, Evgeny Ilich Maevsky, Genrikh Romanovich Ivanitsky, Sergei Jurievich Pushkin, Igor Alexeevich Maslennikov